Ovid Therapeutics Inc. Business Finance Contracts & Agreements

12 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Underwriting Agreement related to the Offering, dated August 25, 2020, among Ovid Therapeutics Inc. and Cowen and Company, LLC and William Blair & Company, L.L.C
Underwriting Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2020
Underwriting Agreement related to the Preferred Offering, dated October 4, 2019, among Ovid Therapeutics Inc. and Cowen and Company, LLC and William Blair & Company, L.L.C
Underwriting Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2019
Underwriting Agreement related to the Common Offering, dated October 4, 2019, among Ovid Therapeutics Inc. and Cowen and Company, LLC and William Blair & Company, L.L.C
Underwriting Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2019
Exchange Agreement among Ovid Therapeutics Inc. and Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P. and Biotechnology Value Trading Fund OS, L.P., dated...
Exchange Agreements
Ovid Therapeutics Inc.
Biotechnology
2019
Form of Series A Preferred Stock Certificate
Stock Agreements
Ovid Therapeutics Inc.
Biotechnology
2019
Underwriting Agreement related to the Preferred Offering, dated February 20, 2019, among Ovid Therapeutics Inc. and Cowen and Company, LLC and William Blair & Company, L.L.C
Underwriting Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2019
Underwriting Agreement related to the Common Offering, dated February 20, 2019, among Ovid Therapeutics Inc. and Cowen and Company, LLC and William Blair & Company, L.L.C
Underwriting Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2019
Signature(s) Guaranteed: Medallion Guarantee Stamp
Guarantee Agreements
Ovid Therapeutics Inc.
Biotechnology
2017
OVID THERAPEUTICS INC. 2017 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:[ ] APPROVED BY THE STOCKHOLDERS:[ ]
Stock Agreements
Ovid Therapeutics Inc.
Biotechnology
2017
Ovid Therapeutics Inc. [] Shares Common Stock ($0.001 par value) Underwriting Agreement
Underwriting Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2017
SERIES B-1 PREFERRED STOCK PURCHASE AGREEMENT TABLE OF CONTENTS
Stock Agreements
Ovid Therapeutics Inc.
Biotechnology
NY
2017
SECOND AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT TABLE OF CONTENTS
Investor Rights Agreements
Ovid Therapeutics Inc.
Biotechnology
DE
2017